Malignant pheochromocytoma and paraganglioma: Three cases illustrating the use of molecular targeted diagnostics and therapy and possible role of new drugs

Author： Zukauskaite Ruta   Hjorthgau Karin   Poulsen Per Logstrup   Baerentzen Steen   Ladekarl Morten  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.50, Iss.8, 2011-11, pp. : 1255-1259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Update on the Systemic Therapy of Malignant Salivary Gland Cancers: Role of Chemotherapy and Molecular Targeted Agents

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 6, 2004-11 ,pp. : 543-551

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapy in malignant mesothelioma

By Bréchot Jeanne-Marie  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 217-221

Springer Publishing Company

Access to resources Recommend Favorite

Imaging of pheochromocytoma and paraganglioma

By Brink I.   Hoegerle S.   Klisch J.   Bley T.  

Familial Cancer, Vol. 4, Iss. 1, 2005-03 ,pp. : 61-68

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Therapy for Cancer: Integrating Diagnostics and Therapeutics

By Jeffrey S. Ross  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 205-214

Adis International

Access to resources Recommend Favorite

The use of molecular diagnostics in bladder cancer

By Han M.   Schoenberg M.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 3, 2000-04 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite